Incyte Genomics (INCY) Form 144 Discloses Option Exercise and Proposed Sale

Rhea-AI Filing Summary

Incyte Genomics Inc (INCY) filed a Form 144 reporting a proposed sale of 277 common shares on 08/15/2025 through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of $24,046.37 and shows 195,276,145 shares outstanding, and the shares were acquired the same day via a stock option exercise with payment in cash.

The filing also discloses five recent sales by Sheila Denton within the prior three months: 1,795 shares on 06/03/2025; 599 on 07/02/2025; 3,330 on 07/15/2025; 785 on 07/16/2025; and 598 on 08/04/2025, with gross proceeds reported for each sale. The filer certifies no undisclosed material adverse information and the form identifies Morgan Stanley as broker of record.

Positive

• Required disclosure provided for proposed sale including broker, acquisition method, payment type, and aggregate market value
• Recent sales history disclosed for the past three months, enhancing transparency

Negative

• Insider selling activity by the same individual (multiple transactions totaling several thousand shares) could be viewed unfavorably by some investors
• Form lacks issuer identity details in the provided content (issuer address and SEC file number are not shown)

Insights

Securities Analyst

TL;DR Insider exercised options and plans a small secondary sale; recent insider dispositions are disclosed but represent a tiny fraction of outstanding stock.

The filing documents a routine Form 144 tied to a same-day stock option exercise and a proposed sale of 277 shares valued at about $24k. With 195.3 million shares outstanding, the planned sale is immaterial to capitalization. Recent sales by the same individual show ongoing liquidity events but no indication of company-level disclosure issues. For investors, these are compliance-level disclosures rather than signals of operational change.

Compliance Officer

TL;DR Form 144 appears complete for the transaction and includes required past three-month sales; signature and broker details are provided.

The form lists the broker

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	277	24046.37	195276145	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Stock Option Exercise	ISSUER			277	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	08/04/2025	598	45310.46
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/16/2025	785	53662.60
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/15/2025	3330	232633.80
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/02/2025	599	41097.39
SHEILA DENTON 1801 Augustine Cut-Off Wilmington DE 19803	Common	06/03/2025	1795	122060.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for INCY report?

The Form 144 reports a proposed sale of 277 common shares of INCY on 08/15/2025 via Morgan Stanley, with aggregate market value $24,046.37.

How were the 277 INCY shares acquired according to the filing?

The shares were acquired on 08/15/2025 through a stock option exercise and payment was made in cash.

Who is the broker handling the proposed INCY sale?

The filing names Morgan Stanley Smith Barney LLC as the broker for the proposed sale.

What recent insider sales by the seller are reported for INCY?

The filing lists sales by Sheila Denton: 1,795 shares on 06/03/2025; 599 on 07/02/2025; 3,330 on 07/15/2025; 785 on 07/16/2025; and 598 on 08/04/2025, with gross proceeds shown for each sale.

How material is the proposed 277-share sale relative to INCY outstanding shares?

With 195,276,145 shares outstanding, the proposed sale of 277 shares is immaterial to the company’s total market capitalization.